⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
M&A Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026 | Life Sciences M&A Surges as 2,500+ Pharmaceutical, Biotechnology and Diagnostics Deals Reshape Industry Competition
globenewswire.com
JNJ
NVS
Global Smart Pills Market Set for Expansion Through 2034 as Targeted Drug Delivery, Diagnostics and Digital Health Adoption Accelerate Worldwide
globenewswire.com
GE
NVS
An Open Letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi
globenewswire.com
AZN
BMY
GSK
NVO
NVS
ROG
SNY
Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move First
globenewswire.com
NVS
PFE
SNY
AZN
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
prnewswire.com
NVS
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
globenewswire.com
ABBV
AMGN
JNJ
TAK
UCB
MRK
PFE
GILD
LLY
NVS
AZN
BHC
ZERO Prostate Cancer Concludes Fifth Annual Support Group Leader & MENtor Training with Record Engagement and Expert-Led Learning
prnewswire.com
PFE
NVS
AZN
SNY
The Pharmaceutical Filtration Market - $25.8+ Billion Global Outlook & Assessment 2026-2032
globenewswire.com
AMAT
AMGN
BMY
CHTR
CRSP
DHR
GILD
GOOG
INTC
JNJ
LLY
MRK
MSFT
NVS
ORCL
PFE
REGN
ROST
SAN
SPGI
TMO
VRTX
XRAY
Highlights to be presented at Novo’s Capital Markets Day 2026
globenewswire.com
NVO
LLY
AZN
GILD
JNJ
ABBV
NVS
SAN
ROG
GSK
AMGN
MRK
REGN
PFE
BMY
Novartis AG (NVS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVS